Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials

被引:26
作者
Xu, Lijuan [1 ]
Wan, Xuesi [1 ]
Huang, Zhimin [1 ]
Zeng, Fangfang [2 ]
Wei, Guohong [1 ]
Fang, Donghong [1 ]
Deng, Wanping [1 ]
Li, Yanbing [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China
来源
PLOS ONE | 2013年 / 8卷 / 04期
关键词
GLOMERULAR-FILTRATION-RATE; TYPE-2; DIABETIC-PATIENTS; SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; NONDIABETIC NEPHROPATHIES; DOUBLE-BLIND; D-RECEPTOR; PARICALCITOL; ALBUMINURIA; PROTEINURIA;
D O I
10.1371/journal.pone.0061387
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Objectives: Recent studies have supported a role for both newer and more established vitamin D compounds in improving proteinuria, although systematic evaluation is lacking. Furthermore, concerns remain regarding the influence of vitamin D on the progression of renal function. We analyzed the efficacy and safety of vitamin D in non-dialysis patients and compared the use of newer versus established vitamin D compounds by performing a meta-analysis of randomized controlled trials. Design: A literature search of PubMed (1975 to September, 2012), EMBASE.com (1966 to September, 2012) and Ovid EBM Reviews (through September, 2012) was conducted. Results: Eighteen studies were eligible for final inclusion; of these, six explored the effects of vitamin D on proteinuria, twelve studied the effects of supplementation on renal function, and fifteen discussed the incidence of hypercalcemia. Compared to the placebo or no interference, both the newer and established vitamin D sterols reduced proteinuria to a similar extent (RR, 2.00; 95% CI, 1.42 to 2.81). No decrease in the glomerular filter rate was observed (SMD, -0.10; 95% CI, -0.24 to 0.03), and the risk for dialysis initiation was 1.48 (95% CI, 0.54 to 4.03) with vitamin D treatment. Additionally, there was an increased risk of hypercalcemia for patients treated with either newer or established vitamin D compounds as compared with the controls (RR, 4.78; 95% CI, 2.20 to 10.37). The head-to-head studies showed no differences in the effects of either newer or established compounds on proteinuria or the risk of hypercalcemia. No serious adverse events were associated with the administration of vitamin D. Conclusions: Vitamin D therapy appears to decrease proteinuria and have no negative influence on renal function in non-dialysis patients. But the occurrence of hypercalcemia should be evaluated when vitamin D is provided. No superiority for newer versus established vitamin D analogue is found.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Vitamin D supplementation and risk of stroke: A meta-analysis of randomized controlled trials
    Fu, Jia
    Sun, Junfang
    Zhang, Chao
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [22] Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
    Panpan Cai
    Xiaohong Tang
    Wei Qin
    Ling Ji
    Zi Li
    International Urology and Nephrology, 2016, 48 : 571 - 584
  • [23] Efficacy of vitamin D supplementation on depressive symptoms in older patients: a meta-analysis of randomized controlled trials
    Fu, Jiamin
    Zhang, Yuchi
    Chen, Xiaoyu
    Yu, Xing
    Yan, Maoxin
    Jing, Biying
    Yu, Hongjuan
    Li, Wenzhen
    Guo, Qi
    FRONTIERS IN MEDICINE, 2024, 11
  • [24] Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials
    Yifeng Xie
    Peiling Su
    Yifan Sun
    Hongsheng Zhang
    Rong Zhao
    Liang Li
    Lanfen Meng
    BMC Nephrology, 18
  • [25] Impact of vitamin D supplementation on the outcome of tuberculosis treatment: a systematic review and meta-analysis of randomized controlled trials
    Xia Jingyan
    Shi Liyun
    Zhao Lifang
    Xu Feng
    CHINESE MEDICAL JOURNAL, 2014, 127 (17) : 3127 - 3134
  • [26] Vitamin D supplementation for depression in older adults: a meta-analysis of randomized controlled trials
    Park, Yoonjung
    Ah, Young-Mi
    Yu, Yun Mi
    FRONTIERS IN NUTRITION, 2023, 10
  • [27] The role of vitamin D in the prevention and treatment of tuberculosis: a meta-analysis of randomized controlled trials
    Meng, Jiahao
    Li, Xi
    Xiong, Yilin
    Wu, Yumei
    Liu, Pan
    Gao, Shuguang
    INFECTION, 2024, : 1129 - 1140
  • [28] Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency A Meta-analysis of Randomized Controlled Trials
    Bischoff-Ferrari, Heike A.
    Willett, Walter C.
    Wong, John B.
    Stuck, Andreas E.
    Staehelin, Hannes B.
    Orav, John
    Thoma, Anna
    Kiel, Douglas P.
    Henschkowski, Jana
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (06) : 551 - 561
  • [29] Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials
    Pathak, K.
    Soares, M. J.
    Calton, E. K.
    Zhao, Y.
    Hallett, J.
    OBESITY REVIEWS, 2014, 15 (06) : 528 - 537
  • [30] Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials
    Alexandrou, Maria-Eleni
    Papagianni, Aikaterini
    Tsapas, Apostolos
    Loutradis, Charalampos
    Boutou, Afroditi
    Piperidou, Alexia
    Papadopoulou, Dorothea
    Ruilope, Luis
    Bakris, George
    Sarafidis, Pantelis
    JOURNAL OF HYPERTENSION, 2019, 37 (12) : 2307 - 2324